SkipNav
Heart & Vascular Center
YNHH

Mechanical Heart and Heart Transplant

Implantable Ventricular Assist Devices

For patients not eligible for heart transplantation, Yale-New Haven's Heart Failure and Transplantation program can offer medical cardiac support with a ventricular assist device (VAD). VADs are surgically implanted medical pumps that take over much of the work for the heart. VADs may be used as a "bridge" to heart transplant, or as a primary treatment for advanced heart failure patients not eligible for heart transplantation, called destination therapy. The Heart Failure and Transplantation program offers an array of FDA-approved devices including the Thoratec HeartMate II® and Thoratec HeartMate® XVE.

LVAD as a permanent solution

FPO

Yale-New Haven Hospital (YNHH) has received certification from the Joint Commission - the nation's predominant standards-setting and accrediting body in health care - to implant left ventricular assist devices (LVADs) into patients with end-stage heart failure as a permanent or destination therapy, not just as a temporary bridge to transplant..

Heart Transplantation

Yale-New Haven Transplantation Center (YNHTC) provides expert, comprehensive and compassionate care for adult and pediatric patients throughout the world who are candidates for organ transplantation. YNHTC team members perform liver, kidney, pancreas and heart transplantation. It is the region's leader in the evaluation and treatment of advanced liver disease.

In addition, YNHTC provides vascular access for patients who require dialysis treatment. YNHTC offers innovative treatments and access to research trials for patients suffering from a wide range of conditions.

Our Physicians

Use our online tool to find a doctor



Yale School of Medicine
Magnet Recognition Best Hospitals 2012-2013

Video Library

Video Library